SMS Lifescience India acquires stake in Mahi Drugs

13 Aug 2018 Evaluate

SMS Lifescience India has acquired 28,15,100 equity shares of Rs 10 each (59.70%) in Mahi Drugs on August 02, 2018. With this, the total stake of the company as on date in Mahi Drugs amounts to 78.79%.

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.

SMS Lifesciences Share Price

767.40 -5.40 (-0.70%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.